4.6 Editorial Material

Regramming myeloid responses to improve cancer immunotherapy

Journal

ONCOIMMUNOLOGY
Volume 4, Issue 6, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/2162402X.2014.974399

Keywords

cancer immunotherapy; immune checkpoints; PD-1; macrophages; MDSCs

Ask authors/readers for more resources

Infiltration by immunosuppressive myeloid cells helps tumors to overcome immune surveillance and can render patients less responsive to therapeutic intervention. Several recent studies have demonstrated that reprogramming myeloid responses can effectively enhance cancer immunotherapy, suggesting several new potential combination therapies for clinical testing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available